| Thursday, 17 November 2011 |
| 10:00-14:00 |
: |
Registration
12:30-14:00 Lunch
|
| HALL A |
|
|
| 14.00-14.10 |
: |
Welcome and Congress Opening
14:00-14:05 Haluk Onat (Turkey),
14:05-14:10 Dimitris Bafaloukos (Greece)
|
14.10-14.55
Chairpersons: |
: |
Differences of Cancer Profile in Mediterranean Region
Bülent Berkarda (Turkey), Paris Kosmidis (Greece)
14:15-14:35 Greece and Europe - Michael Karamouzis (Greece)
14:35-14:55 Turkey - Murat Gültekin(Turkey)
|
15.00-17.00
Chairpersons: |
: |
Urologic Tumors (I) Renal Cell Carcinoma
Tarık Esen (Turkey), George Pentheroudakis (Greece)
15:00-15:30 Pathology, Prognostic Factors – Konstantina Frangia (Greece)
15:30-16:00 The Role of Surgery in Targetted Therapy Era – Can Öbek (Turkey)
16:00-16:30 Optimization of Targetted Therapies – Aristotelis Bamias (Greece)
16:30-17:00 Treatment of mRCC beyond TKI/VEGF Targetted Therapies – Camillo Porta (Italy)
|
| HALL B |
|
|
15.00-17.00
Chairpersons: |
: |
Malignant Melanoma
İsmail Çelik (Turkey), Sıdıka Kurul (Turkey)
15:00-15:40 Adjuvant Therapy – Axel Hauschild (Germany)
15:40-16:20 Treatment of Metastatic Melanoma – Dimitris Bafaloukos (Greece)
16:20-17:00 Molecular Biology Markers in the Selection of Patients – Helen Gogas (Greece)
|
| 17.00-17.30 |
: |
Coffee Break
|
| HALL A |
|
|
17.30-19.00
Chairpersons: |
: |
Urologic Tumors (II)
Berksoy Şahin (Turkey), Vassileios Georgoulias (Greece)
17:30-18:00 Is There a Role of High Dose Chemotherapy in Testicular Cancer ? - Giovanni Rosti (Italy)
18:00-18:30 Medical Management of Muscle Invasive Bladder Cancer - Nasr Allahloubi (Egypt)
18:30-19:00 New Drugs in Prostate Cancer – Mustafa Özgüroğlu (Turkey)
|
| HALL B |
|
|
17.30-19.00
Chairpersons: |
: |
Oral Presentations (I)
Bülent Karabulut (Turkey), Ioannis Varthalitis (Greece)
|
| 17.30 |
: |
Clinicopathologic Characteristics and Survival Rate of In-patients with BRCA1/2 Linked
Ovarian Cancer (OC) in Turkey - Fatma Aydoğan (Turkey)
|
| 17.40 |
: |
Prevalence of BRCA1 Mutations in 676 Unselected Greek Ovarian Cancer Patients-
A Hellenic Cooperative Oncology - Alexandra Stavropoulou (Greece)
|
| 17.50 |
: |
Prevalence Of BRCA1 Mutations Among 403 Women with Triple-Negative Breast
Cancer: Implications for Genetic Screening Selection Criteria - A Hellenic Cooperative
Oncology Group Study - Florentia Fostira (Greece)
|
| 18.00 |
: |
The Access Rate to Diagnosis and Treatment Modalities in Breast Cancer Patients
in Turkey; Multicenter Observational Study - Serkan Keskin (Turkey)
|
| 18.10 |
: |
Prognostic Significance of Racgap1 Mrna Expression in High-Risk Early Breast Cancer.
A Hellenic Cooperative Oncology Group (HeCOG) Study - Konstantınos Kalogeras (Greece)
|
| 18.20 |
: |
Clinical and Pathological Features of Breast Cancer (BC) Associated with Pathological
Complete Response to Anthracycline Based Neoadjuvant Chemotherapy (NAC) -
Serkan Keskin (Turkey)
|
| 18.30 |
: |
A Clinical Audit of Data Regarding Gist Patients. A Single Centre Experience - Anna Koumarianou (Greece)
|
| 18.40 |
: |
Noncutaneous Melanoma Have Distinct Features from Each Other and Cutaneous
Melanoma - Fatma Şen (Turkey)
|
| 18.50 |
: |
The Combination of Cisplatin - Vinblastine -Temozolomide (Pvt) As 1st Line Treatment
of Patients with Metastatic Melanoma: A Phase II Study of The Hellenic Cooperative
Oncology Group (Hecog) - Helen Linardou (Greece)
|
| HALL A |
|
|
| 19:30-21:30 |
: |
Congress Opening Ceremony
19:30-20:00 Award Ceremony
20:00-20:30 Music Performance under the direction of Prof. Saim Akçıl,
20:30-21:30 Welcome Cocktails
|
| Friday, 18 November 2011 |
| HALL A |
|
|
08.30-10.30
Chairpersons: |
: |
Breast Cancer (I)
George Asimakopoulos (Greece), Cihan Uras (Turkey)
08:30-09:10 Radiology Screening – Gül Esen İçten (Turkey)
09:10-09:50 Pathology Molecular Markers – Gülnur Güler (Turkey)
09:50-10:30 Surgery (Approach to the Axilla, Oncoplastic Surgery) – George Filippakis (Greece)
|
| HALL B |
|
|
08.30-10.30
Chairpersons: |
: |
High Grade Brain Tumors
Faruk Zorlu (Turkey), Dimitris Rologis (Greece)
08:30-09:00 Modern Neuroimaging Technics for Brain Tumors: Diagnosis and Monitoring –
Naci Koçer (Turkey)
09:00-09:30 Surgery: Extent of Resection, Navigation, Reresection for Relapse – Evren Keleş (Turkey)
09:30-10:00 Radiotherapy: New Modalities – Louiza Vini (Greece)
10:00-10:30 Chemotherapy and Targetted Therapies for GBM – Fulden Yumuk (Turkey)
|
| 10.30-11.00 |
: |
Coffee Break
|
| HALL A |
|
|
11.00-13.00
Chairpersons: |
: |
Breast Cancer (II)
Rabab Gaafar (Egypt), George Fountzilas (Greece)
11:00-11:40 Tripple Negative Breast Cancer – Gül Başaran (Turkey)
11:40-12:20 Metastatic HER2 Positive Breast Cancer – Fuat Demirelli(Turkey)
12:20-13:00 Treatment Beyond Disease Progression and Resistance to Trastuzumab –
Fuat Demirelli (Turkey)
|
| HALL B |
|
|
11.00-13.00
Chairpersons: |
: |
Head & Neck Cancer
Mert Başaran (Turkey), Enis Özyar (Turkey)
11:00-11:30 Is There a Role for Neoadjuvant Therapy in HNC Surgery? Şefik Hoşal (Turkey)
11:30-12:00 Radiotherapy Technics – Mahmut Özşahin (Switzerland)
12:00-12:30 Recent Developments in HNC – Amanda Psyrri (Greece)
12:30-13:00 Anti EGFR (MOAB and TKI) Toxicity – Janja Ocvirk (Slovenia)
|
13.00-14.00
Chairpersons: |
: |
Lunch Session - Anadolu Hall
Dimosthenis Skarlos (Greece), Dilek Dinçol (Turkey)
13:15-14:00 The Future of Molecular Targetted Therapy of Cancer – Yosef Yarden (Israel)
|
| HALL A |
|
|
14.00-16.00
Chairpersons: |
: |
Breast Cancer (lll)
Handan Onur (Turkey), Osman Mansour (Egypt)
14:00-14:30 Adjuvant Systemic Chemotherapy – Başak Oyan Uluç(Turkey)
14:30-15:00 Neoadjuvant Chemotherapy – Jose Ignacio Mayordomo (Spain)
15:00-15:30 Adjuvant Hormonal Therapy – Yeşim Eralp (Turkey)
15:30-16:00 Adjuvant Radiotherapy: New Approaches and Fractionation – Nuran Beşe (Turkey)
|
| 16:00-16:30 |
: |
Coffee Break
|
| HALL B |
|
|
14.00-16.00
Chairpersons: |
: |
Neuroendocrine Tumors (NET)
İdris Yücel (Turkey), Thomas Makatsoris (Greece)
14:00-14:30 Pathology: GIS and nonGIS (lung, etc) – Mauro Papotti (Italy)
14:30-15:00 Surgical Approach to NET – Ahmet Çoker (Turkey)
15:00-15:30 Medical Treatment of NET – Marianne Pavel (Germany)
15:30-16:00 Radionuclide Therapy in NET – Levent Kabasakal (Turkey)
|
| HALL C |
|
|
14.30-16.00
Chairpersons: |
: |
Oral Oncology
Hakkı Tanyeri (Turkey), Meral Ünür (Turkey)
14:30-14:55 Advances in Treatment of Mucositis Caused by Cancer Therapies - Douglas E.Peterson (USA)
15:00-15:30 Drug - Related Osteonecrosis of the Jaws - Ourania Nicolatou Galitis (Greece)
15:30-15:45 Dental Extractions in Bisphosphonate Related Osteonecrosis of the Jaws -
Erofili Papadopoulou (Greece) & Emmanouil Vardas (Greece)
15:45-16:00 Xerostomia in Cancer: The Relation to Oral Candidiasis and Dental Disease, Therapeutic Protocols - Efstratia Gatou (Greece) & Sertan Ergün (Turkey)
16:00-16:15 Recurrent Oral Squamous Cell Carcinoma: Awareness and Clinical Presentations - Kıvanç Bektaş Kayhan (Turkey) & Emmanouil Vardas (Greece)
|
| 16:15-16:30 |
: |
Discussion
|
| HALL A |
|
|
16.30-18.30
Chairpersons: |
: |
Ovarian Cancers
Nilüfer Güler (Turkey), Dimitrios Pectasides (Greece)
16:30-17:00 Optimal Surgery for Ovarian Cancer – Fırat Ortaç (Turkey)
17:00-17:30 New Standards in Chemotherapy for Ovarian Cancer – Sandro Pignata (Italy)
17:30-18:00 Recurrent Ovarian Cancer: Is There a Role for Targetted Therapies? -
Isabella Ray Coquard (France)
18:00-18:30 Novel Approaches to Preserving Fertility in Cancer Patients – Semra Kahraman (Turkey)
|
| HALL B |
|
|
16.30-18.00
Chairpersons: |
: |
Oral Presentations II
Alper Sevinç (Turkey), Anna Koumarianou (Greece)
|
| 16.30 |
: |
Activation of Akt/Mtor Signaling Pathway Promotes Cell Proliferation and Vasculogenesis
in Tumors of Patients with Locally Advanced Nasopharyngeal Cancer Treated with
Chemo-Radiotherapy. A Translational Study Performed in the Context of a Hellenic
Cooperative Oncology Group (Hecog) Randomised Trial - Mattheos Bobos (Greece)
|
| 16.40 |
: |
Frequency of EGFR Mutations in Greek Non-Small-Cell Lung Cancer (NSCLC) patients - Samuel Murray (Greece)
|
| 16.50 |
: |
Prognostic Significance of EGFR Gene Copy Number Gain in NSCLC: A Systematic
Review and Meta-analysis - Samuel Murray (Greece)
|
| 17.00 |
: |
Investigation of Sentinel Lymph Nodes Using SPECT/CT and Perioperative Gamma
Assay Combined With Immunohistochemistry in NSCLC Patients Undergoing Lung
Resection - Okan Falay (Turkey)
|
| 17.10 |
: |
Importance of Pathological Review and Methodological Selection for Somatic KRAS
Testing in Colorectal Cancer - Samuel Murray (Greece)
|
| 17.20 |
: |
Molecular Analysis of Tumour Biomarkers for Prognostic and Predictive Utility in
Patients with Cetuximab-Treated Colorectal Cancer – George Pentheroudakis (Greece)
|
| 17.30 |
: |
Her2/neu,Bcl-2 and P53 Overexpression Significant Impact on Survival in Colorectal
Cancer (Using Tissue Microarray) - Ola Khorshid (Egypt)
|
| 17.40 |
: |
Robotic surgery for Rectal Cancer: Initial Experience from 30 Consecutive Patients - İlknur Ergüner (Turkey)
|
| 17.50 |
: |
Predictive Significance of Marker Half-life During Chemotherapy in Relapsed and
Non - Relapsed Patients with Non - Seminomatous Germ Cell Testicular Tumors - Serkan Keskin (Turkey)
|
| HALL C |
|
|
| Saturday, 19 November 2011 |
| HALL A |
|
|
08.30-10.30
Chairpersons |
: |
Lung Cancer (I)
Cengiz Gebitekin (Turkey), Epameinondas Samandas (Greece)
08:30-09:10 Surgical Staging – Ugo Pastorino (Italy)
09:10-09:50 Approach to Solitary Pulmonary Nodule – Levent Tabak (Turkey)
09:50-10:30 The Role of PET/CT for Diagnosis, Treatment and Monitoring – Kerim Sönmezoğlu (Turkey)
|
| HALL B |
|
|
08.30-10.30
Chairpersons: |
: |
Gastrointestinal Cancer (I)
Faruk Aykan (Turkey), Pavlos Papakostas (Greece)
08:30-09:00 Controvertial Issues in Esophageal Cancers – Heinz Josef Lenz (USA)
09:00-09:30 Developments in Metastatic Gastric Cancer – Fairooz Kabbinavar (USA)
09:30-10:00 Surgical Approaches for Colorectal Cancer – İsmail Hamzaoğlu (Turkey)
10:00-10:30 The Art of Radiotherapy for Rectal Cancer – Uğur Selek (Turkey)
|
| 10.30-11.00 |
: |
Coffee Break
|
| HALL A |
|
|
11.00-12.30
Chairpersons: |
: |
Lung Cancer (ll)
Pınar Saip (Turkey), Helena Linardou (Greece)
11:00-11:30 Histology Oriented Approach – Mauro Papotti (Italy)
11:30-12:00 Recent Developments in Radiation Therapy – Umberto Ricardi (Italy)
12:00-12:30 Beyond First Line Therapies and Maintenance Therapies – Giorgio Scagliotti (Italy)
|
| HALL B |
|
|
11.00-12.30
Chairpersons: |
: |
Gastrointestinal Cancer (II)
Şuayib Yalçın (Turkey), Necdet Üskent (Turkey)
11:00-11:30 BPersonalized Therapies in mCRC – From Medical Treatment to Surgery -
Heinz Josef Lenz (USA)
11:30-12:00 BMetastasectomy to Whom and When? - Alihan Gürkan (Turkey)
12:00-12:30 BAntiVEGF treatments for Metastatic Colorectal Cancer – Fairooz Kabbinavar (USA)
|
| 12.30-14.00 |
: |
Lunch – Satellite Symposium (MSD Antiemetic Therapy) Anadolu Hall
Speaker: Karin Jordan (Germany)
|
| HALL A |
|
|
14.00-16.00
Chairpersons: |
: |
Lung Cancer (III)
Ahmet Demirkazık (Turkey), Samuel Murray (Greece)
14:00-14:40 Targetted Therapies – Federico Capuzzo (Italy)
14:40-15:20 Neoadjuvant Radiochemotherapy – Marina Garassino (Italy)
15:20-16:00 Is There a Role for Surgery in Stage III-B Disease? – Ugo Pastorino (Italy)
|
| HALL B |
|
|
14.00-16.00
Chairpersons: |
: |
Gastrointestinal Cancer (III) GIST
Erhan Gökmen (Turkey), Christos Dervenis (Greece)
14:00-14:30 Pathology, Prognostic Information – Eva Wardelmann (Germany)
14:30-15:00 Management of Primary GIST – Dursun Buğra (Turkey)
15:00-15:30 Management of High Risk Patient – Robert Maki (USA)
15:30-16:00 New Agent in GIST – Sevil Bavbek (Turkey)
|
| 16.00-16.30 |
: |
Coffee Break
|
| HALL A |
|
|
16.30-18.30
Chairpersons: |
: |
Arome & MMOF Joint Meeting Palliative and Supportive Care
Yazid Belkacemi (France), Sedat Turkan (Turkey), Athina Christopoulou (Greece)
16:30-17:10 Physiopathology of Iron Deficiency in Cancer Patients – Sigismond Lasocki (France)
17:10-17:50 Clinical Experience with IV Iron – Gilbert Deray (France)
17:50-18:30 Paradise Program: How to Overcome Inequalities of Pain Management – Gil Barsela (Israel)
|
| HALL B |
|
|
16.30-18.30
Chairpersons: |
: |
Hepatocellular Cancer
Necdet Üskent (Turkey), Dimitrios Mavroudis (Greece)
16:30-17:00 Staging Algorithm and Surgery – Yaman Tokat (Turkey)
17:00-17:30 Local Therapies (RFA/CE) – İzzet Rozanes (Turkey)
17:30-18:00 Local Therapies (Radionuclide Therapy) – George Limouris (Greece)
18:00-18:30 Targetted Therapies in HCC – Heba Zawahry(Egypt)
|
| HALL C |
|
|
